Compare DigiByte (DGB) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DigiByte vs Enzyme — how do they compare? DigiByte trades at Rp72.15 (market cap Rp1,33T, Rp44,83M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: DigiByte is far larger — about 9915.8× Enzyme's market cap, and DigiByte's supply is capped (18,4B / 21B DGB (88%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold DigiByte for 22 Days and Enzyme for 29 Days on average.
| DGB | MLN | |
|---|---|---|
Market Cap | Rp1,33T | Rp134,13M |
Volume (24h) | Rp44,83M | Rp104,56M |
Circulating Supply | 18,4B / 21B DGB (88%) | 3,3M MLN |
Typical Hold Time | 22 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DigiByte is trading at Rp73.499 with a market cap of Rp1.35T, showing bullish technical signals with strong moving average support and key indicators favoring buying activity. The asset maintains 88% circulation rate with support levels at Rp69-72 and resistance at Rp75-78. Recent technical momentum suggests upward potential despite neutral RSI readings.
Overall outlook remains positive with strong technical momentum, though investors should monitor resistance levels and cryptocurrency market volatility. Key opportunities include potential breakout above resistance, while risks involve typical crypto volatility and regulatory uncertainties affecting the broader digital asset space.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About DigiByte
DigiByte (DGB) is an open-source blockchain and asset creation platform. Its development started in October 2013, and its genesis block was mined in January 2014 as a fork of Bitcoin (BTC).
Read more on DGB →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
